Identity
- Security key
- 13125
- Ticker
- CATX
- Type
- CS — Common Stock
- Exchange
- NYSE American, LLC(XASE)
- Venue group
- NYSE
- Operating MIC
- XNYS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2003-12-29
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- CATX
Detail
Enriched 2026-08-14 20:47
- Market cap
- $372,134,421.38
- Shares outstanding (class)
- 114,046,197
- Shares outstanding (weighted)
- 114,151,663
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 166
- Location
- SEATTLE, WA
- Description
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.